Drug Product
Company Overview
About
MFC Co., Ltd. is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Solid Dose Manufacturing, Oral Liquids, Topicals
Therapeutic Areas
Oncology
Hematology
Quick Facts
HQ:South Korea
Founded:2018
Employees:2,491
Capabilities & Services
Core Capabilities
- Oral Solid Dose
- Solid Dose Manufacturing
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Lyophilized (Freeze-Dried)
Sterile Injectable
Containment Capabilities
Cytotoxic / ADC Handling
Production Scales
Pilot Scale
Phase I Clinical Trials
Clinical
Markets Served
North America
Regulatory Approvals
Drug Approval LE5YTB
PMDA · #APR-SLESW3KG · 2018-10-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-FO2FP83D
Issued: 2020-09-17
Expires: 2025-06-20
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-CB2PEV8K
Issued: 2020-07-25
Expires: 2025-08-04
ISO 13485:2016
International Organization for Standardization
Cert #: CERT-1ACHDPKF
Issued: 2020-09-20
Expires: 2025-04-09
Health Canada GMP
Health Canada
Cert #: CERT-IB1MVSFZ
Issued: 2020-01-18
Expires: 2025-12-16
Loading CDMO intelligence...
Key facts about MFC Co., Ltd.
- MFC Co., Ltd. is headquartered in South Korea.
- MFC Co., Ltd. was founded in 2018.
- MFC Co., Ltd. has 2,491 employees.
- MFC Co., Ltd.'s capabilities include Oral Solid Dose, Solid Dose Manufacturing and Formulation Development.
Find CDMOs like MFC Co., Ltd.
Directory pages this company appears in, each with the full list of matching manufacturers.